Summit Global Investments Amphastar Pharmaceuticals, Inc. Transaction History

Summit Global Investments

$1.57 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$45.51 - $65.0 $746,090 - $1.07 Million	16,394 Added 82.61%	36,238 $1.67 Million
Q2 2023 Jul 18, 2023	SELL	$35.77 - $58.38 $624,401 - $1.02 Million	-17,456 Reduced 46.8%	19,844 $1.14 Million
Q1 2023 May 04, 2023	BUY	$27.99 - $37.92 $218,322 - $295,776	7,800 Added 26.44%	37,300 $1.4 Million
Q4 2022 Jan 31, 2023	BUY	$27.93 - $31.27 $262,542 - $293,938	9,400 Added 46.77%	29,500 $827,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $912,621 - $1.25 Million	-33,114 Reduced 62.23%	20,100 $565,000
Q2 2022 Aug 23, 2022	BUY	$29.79 - $42.29 $253,632 - $360,057	8,514 Added 19.05%	53,214 $1.85 Million
Q1 2022 Apr 29, 2022	SELL	$22.96 - $36.45 $27,552 - $43,740	-1,200 Reduced 2.61%	44,700 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $264,844 - $340,034	-14,600 Reduced 24.13%	45,900 $1.07 Million
Q3 2021 Nov 08, 2021	BUY	$17.83 - $21.49 $233,572 - $281,519	13,100 Added 27.64%	60,500 $1.15 Million
Q2 2021 Jan 28, 2022	SELL	$17.11 - $20.92 $2,498 - $3,054	-146 Reduced 0.31%	47,400 $956,000
Q1 2021 Jan 27, 2022	SELL	$17.21 - $20.65 $255,275 - $306,301	-14,833 Reduced 23.78%	47,546 $871,000
Q4 2020 Feb 11, 2021	SELL	$17.76 - $21.24 $10,886 - $13,020	-613 Reduced 0.97%	62,379 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$17.99 - $22.22 $9,930 - $12,265	552 Added 0.88%	62,992 $1.18 Million
Q2 2020 Aug 11, 2020	BUY	$14.25 - $22.46 $54,150 - $85,348	3,800 Added 6.48%	62,440 $1.4 Million
Q1 2020 May 14, 2020	BUY	$12.66 - $20.08 $121,536 - $192,767	9,600 Added 19.58%	58,640 $870,000
Q4 2019 Feb 13, 2020	BUY	$17.07 - $20.64 $107,797 - $130,341	6,315 Added 14.78%	49,040 $946,000
Q3 2019 Nov 08, 2019	BUY	$19.12 - $22.62 $816,902 - $966,439	42,725 New	42,725 $847,000

Others Institutions Holding AMPH

# of Institutions

280

Shares Held

36.7M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account